Felix Jaminion
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema.
Journal: Translational vision science & technology
Published: November 13, 2024
Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease.
Journal: Translational vision science & technology
Published: November 13, 2024
Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria.
Journal: British journal of clinical pharmacology
Published: September 05, 2024
Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL-6 levels following administration of the T-cell bispecific engager glofitamab.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 23, 2023
Clinical pharmacology of emicizumab for the treatment of hemophilia A.
Journal: Expert review of clinical pharmacology
Published: August 02, 2023
Efficacy and safety exposure-response analyses of entrectinib in patients with advanced or metastatic solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: October 01, 2021
Pharmacometric analyses of alectinib to facilitate approval of the optimal dose for the first-line treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 08, 2021
How Semiphysiological Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports Phase II Dose Selection of RO7049389, A Novel Anti-Hepatitis B Virus Drug.
Journal: Clinical pharmacology and therapeutics
Published: November 05, 2020
PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: March 13, 2019
Exposure-response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: April 13, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026